However, the significance of LAT1 in tumor aggressiveness, prognosis, and mTOR signaling has not yet been elucidated in CRC patients treated with post-operative adjuvant chemotherapy, including oxaliplatin. This evidence concerns the gene SLC7A5 and colorectal carcinoma.